United States · FDA National Drug Code directory

PRENATE DHA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 75854-312_4faa7802-74fa-e413-e063-6394a90a9a49
Product NDC: 75854-312
Form: CAPSULE, GELATIN COATED
Composition / generic term: ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, folic acid, levomefolate calcium, pyridoxine hydrochloride, cyanocobalamin, calcium formate, ferrous asparto glycinate, magnesium oxide and doconexent
Labeler: Avion Pharmaceuticals, LLC
Marketing category: UNAPPROVED DRUG OTHER
Marketing start / end (source format): 20140605
Source listing expiry: 20271231

Source-listed ingredients

LEVOMEFOLATE CALCIUM — 600 ug/1
ASCORBIC ACID — 90 mg/1
CHOLECALCIFEROL — 10 ug/1
.ALPHA.-TOCOPHEROL, DL- — 18 mg/1
FOLIC ACID — 400 ug/1
PYRIDOXINE HYDROCHLORIDE — 26 mg/1
CYANOCOBALAMIN — 25 ug/1
CALCIUM FORMATE — 160 mg/1
FERROUS ASPARTO GLYCINATE — 18 mg/1
MAGNESIUM OXIDE — 50 mg/1
DOCONEXENT — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-312-30) · 75854-312-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →